DEF 14AThe Ballot
REGENERON PHARMACEUTICALS, INC. files DEF 14A
Filed Apr 21, 2022 · 4y ago · Accession 0000930413-22-000787
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- REGN
- CIK
- 872589
- Form type
- DEF 14A
- Filing date
- Apr 21, 2022
- Report date
- Jun 10, 2022
- Document
- c102797_def14a.htm
- Size
- 17.4 MB